Irena Ivanovska

Celdara Medical

Irena Ivanovska is a pharma and biotech professional with extensive drug and biomarker discovery experience from Merck and Celdara Medical. Under her leadership, teams have delivered new target validation packages, validated screening assays for small molecule inhibitors and identified tumor-specific gene expression signatures. Her diverse therapeutic area expertise spans across oncology, immunology, autoimmune and cardiovascular diseases. She has an extensive publishing record in peer-reviewed journals and has been an invited speaker at several national and international conferences.